Medtronic Reports FY26 Revenue Up 8.4% to $36.36B, EPS Rises to $3.73
MDT is trading near its 52-week low of $73.31 (8.9% above the low) on elevated volume (2.1× avg).
Summary
Medtronic reported full-year 2026 revenue of $36.36 billion, an 8.4% increase from the prior year, with diluted EPS rising 3.3% to $3.73. This news provides the specific audited figures from the company's 10-K filing today, confirming the strong full-year performance previously indicated in early June. The results show broad-based growth, particularly in international markets, despite headwinds from tariffs and higher costs.
At the time of this announcement, MDT was trading at $79.81 on NYSE in the Life Sciences sector, with a market capitalization of approximately $101.9B. The 52-week trading range was $73.31 to $106.33. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.